研究单位：[1]Beijing University of Chinese Medicine, Dongzhimen Hospital, Beijing[2]Beijing Emergency Medical Center[3]Beijing Tiantan Hospital[4]Beijing Hospital of Traditional Chinese Medicine[5]Centre for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine[6]Xuanwu Hospital, Beijing[7]Beijing Friendship Hospital[8]Beijing Chao Yang Hospital[9]Beijing Shijitan Hospital, Capital Medical University[10]Beijing Fengtai Youanmen Hospital[11]Beijing Jiangong Hospital[12]Beijing Chaoyang Emergency Medical Center[13]Beijing Chaoyang Integrative Medicine Emergency Medical Center[14]Guang'anmen Hospital of China Academy of Chinese Medical Sciences[15]Fangshan Hospital，Beijing University of Chinese Medicine[16]Civil Aviation General Hospital[17]The First Hospital of Fangshan District,Beijing[18]Beijing Chinese Medicine Hospital-Pinggu Hospital[19]Beijing Pinggu District Hospital
The main purpose of this trial is to observe whether Xingnaojing, intravenously administered within 24 hours of symptom onset on pre-hospital emergency ambulance, improves the Early neurological deterioration of acute stroke at 3 days.
